X
20
Astellas Pharma Inc. Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Cefixime, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-073 - Rev 00
This TSE Type CEP, issued on July 13, 2006, remains in force until October 12, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1188 associated with this CEP further emphasizes